Skip to main content

Best Performing Stocks Year-to-Date

100 stocks · Updated Nov 3, 2026

Year-to-date performance leaders reflect the stocks generating the most price appreciation since January 1st of the current year. Leading performers include companies reporting earnings beats, receiving regulatory approvals, executing strategic pivots, or simply benefiting from sector momentum. YTD leaders are a useful starting point for momentum research, though historical outperformance does not guarantee future returns and many YTD leaders mean-revert by year end.

StockPriceYTDMarket Cap
AKTSAktis Oncology, Inc.$14.59+39120.40%$884.1M
LIFEEthos Technologies Inc.$40.97+2056.32%$2.77B
BKNGBooking Holdings Inc.$153.30+1689.11%$115.07B
MRNAModerna, Inc.$226.50+668.07%$85.50B
AGLAgilon Health, Inc.$87.31+407.00%$1.52B
CDNACareDx, Inc$88.90+371.87%$4.59B
SNDKSandisk Corporation$1118.70+371.27%$181.47B
TWSTTwist Bioscience Corporation$139.28+339.09%$10.06B
PMIPicard Medical, Inc.$7.64+336.57%$857.5M
IBRXImmunityBio, Inc.$8.21+314.90%$8.79B
TXG10x Genomics, Inc.$65.08+299.02%$8.43B
ERASErasca, Inc.$14.63+293.14%$5.02B
ABTCAmerican Bitcoin Corp$6.61+288.82%$564.4M
DDDuPont de Nemours, Inc.$153.97+283.00%$18.73B
ATEXAnterix Inc.$82.18+276.45%$1.61B
PLSEPulse Biosciences, Inc.$51.66+276.26%$3.73B
MQMarqeta, Inc.$17.71+272.84%$1.74B
MXLMaxLinear, Inc.$63.68+265.35%$6.12B
KODKodiak Sciences Inc.$98.75+253.18%$6.23B
ABCLAbCellera Biologics Inc.$12.04+252.19%$3.98B
SVCService Properties Trust$6.14+233.97%$830.2M
ORKAOruka Therapeutics, Inc.$99.64+228.72%$6.41B
DELLDell Technologies Inc.$408.19+224.27%$297.08B
LULufax Holding Ltd$8.23+221.48%$997.3M
IOVAIovance Biotherapeutics, Inc.$8.71+218.86%$3.84B
AXTIAXT, Inc.$52.02+218.16%$3.61B
AEHRAehr Test Systems$63.55+214.74%$1.79B
SYRESpyre Therapeutics, Inc.$99.02+202.26%$8.91B
ETONEton Pharmaceuticals, Inc.$50.89+200.95%$1.43B
MUMicron Technology, Inc.$853.68+199.11%$1.02T
PAYSPaysign, Inc.$15.15+194.18%$809.7M
ELVNEnliven Therapeutics, Inc.$44.67+190.10%$3.24B
AMNAMN Healthcare Services, Inc.$45.29+187.37%$1.90B
PBFPBF Energy Inc.$77.89+187.21%$9.25B
KOSKosmos Energy Ltd.$2.60+185.98%$1.47B
PURRHyperliquid Strategies Inc Common Stock$10.14+184.97%$1.22B
BANDBandwidth Inc.$43.65+182.49%$1.30B
ABSIAbsci Corporation$9.85+182.24%$1.62B
QMCOQuantum Corporation$17.82+176.28%$798.1M
ECOOkeanis Eco Tankers Corp.$93.35+175.86%$3.31B
PENGPenguin Solutions, Inc.$53.61+174.08%$2.66B
DRTSAlpha Tau Medical Ltd$13.56+174.04%$1.25B
OABIOmniAb, Inc.$5.04+172.16%$721.1M
RNGRingCentral, Inc.$78.48+171.75%$6.08B
RXTRackspace Technology, Inc.$2.60+168.31%$731.5M
CBRLCracker Barrel Old Country Store$67.64+166.30%$1.54B
TNGXTango Therapeutics, Inc.$23.41+164.16%$3.83B
MPCMarathon Petroleum Corporation$429.61+164.16%$132.17B
IBTAIbotta, Inc.$60.00+163.97%$1.13B
NVCTNuvectis Pharma, Inc.$19.38+156.69%$606.2M
Showing 1-50 of 100 stocks

Get Your Daily Market Recap

TickFlow Daily delivers the top gainers, losers, and signals to your inbox every day at market close. Free.

Frequently Asked Questions

Is YTD performance a good predictor of future returns?

Momentum research shows short-term (1-12 month) performance does have some predictive value over the following 1-6 months. However, many YTD leaders experience mean reversion. Past YTD performance is a useful screening input, not a buy signal on its own.

What typically drives the top YTD performers?

Earnings beats, product launches, M&A activity, regulatory approvals (especially in healthcare and cannabis), short squeezes, sector rotations, and macro tailwinds are the most common catalysts for outperformance in any given year.

Should I buy YTD leaders to follow momentum?

Momentum strategies can work but require strict rules around position sizing and exit triggers. Chasing YTD leaders without understanding the fundamental catalyst often means buying after the easy gain is already captured.

How does this list change over time?

This list resets at January 1 each year. Early in the year, even small gains land stocks on the list. By year-end, the list reflects the genuine full-year outperformers. The composition changes significantly as the year progresses.

Related Stock Lists